SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is currently trending as shareholders react to the company's annual meeting proposals, which include authorization for a potential reverse stock split. While some in the community are optimistic about Tonmya prescription growth and recent insider buying, others remain deeply skeptical, citing a long history of dilution and the stock's significant decline since its product launch.

Daddy Darth Vader

The community is currently caught in a "daddy war" rivalry between various tokens, driving intense debate over leadership credibility, alleged market manipulation, and the potential for rapid gains. Discussions are split between investors advocating for loyal community building and skeptics warning of a high-risk environment characterized by potential rug pulls and pump-and-dump mechanics.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering intense community focus as traders weigh long-term infrastructure potential against recent price volatility and concerns over institutional adoption. Conversations are currently polarized between believers in the project's foundational role in tokenized real-world assets and those frustrated by its recent underperformance compared to the broader market.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing heightened community debate as investors weigh strong dividend yields and favorable technical setups against ongoing concerns over pipeline growth and regulatory headwinds from potential pharmaceutical tariffs. While some traders are focused on short-term option signals and a possible breakout above key resistance, others remain skeptical, pointing to the company's historical performance and the competitive pressure in the obesity and oncology markets.

NioCorp Developments Ltd. engages in the evaluation, acquisition, exploration, and development of mineral deposits. It focuses on a super alloy materials project in Nebraska for producing niobium, scandium, and titanium. The company was founded on February 27, 1987, and is headquartered in Centennial, CO.

NioCorp Developments Ltd

NioCorp Developments is trending due to heightened institutional interest and positive technical patterns as the company advances its Elk Creek project. The community is actively discussing the potential impact of long-awaited feasibility study results and imminent debt financing, with many investors weighing these upcoming catalysts against past timeline delays.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is seeing intense investor debate as shareholders weigh the company's defensive cash-heavy strategy against its persistent underperformance compared to the broader market. While some investors view the stock as a stable, undervalued hedge during volatility, others are increasingly vocal about frustration with management's capital allocation and a lack of aggressive growth, particularly as leadership transitions to Greg Abel.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as it positions itself as a critical player in the U.S. defense supply chain, leveraging a fully financed expansion of its heavy rare-earth metallization facility to reduce dependence on Chinese-sourced materials. The community is actively discussing the company's high-level board of directors, recent Department of Defense contracting, and the strategic importance of its domestic processing capabilities as the market prepares for 2027 mandates regarding Chinese-origin rare earth components.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus is generating significant buzz as its community emphasizes long-term conviction and organic growth over short-term hype. Investors are actively discussing its potential for viral expansion within the Solana ecosystem and holding firm despite broader market volatility.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors weigh its unique 'phygital' business model against broader market volatility, with many users debating whether its retail footprint and upcoming product initiatives signal a long-term recovery. Community sentiment is deeply divided between long-term holders advocating for accumulation and skeptics wary of its recent price action and high concentration among top wallets.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos is experiencing increased market interest as investors weigh its role as essential interoperability infrastructure, with the community actively debating the long-term impact of proposed tokenomics redesigns versus current price volatility. Bullish sentiment is being driven by anticipation of institutional adoption and broader macro-economic factors, while skeptics remain vocal regarding competition and the project's ability to maintain utility in an evolving landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KBC Group NV Boosts Position in Jazz Pharmaceuticals PLC $JAZZ

KBC Group NV boosted its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 7.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange...

Jazz Pharmaceuticals Touts Record $4.3B 2025 Revenue, Reaffirms 2026 Outlook at Conference

Jazz Pharmaceuticals (NASDAQ:JAZZ) executives highlighted record 2025 revenue, a growing pipeline anchored by oncology programs, and a refined strategy emphasizing rare diseases during a conference session featuring Chief Financial Officer Philip Johnson and investor relations leaders Jack Spinks an...

Jazz Pharmaceuticals (NASDAQ:JAZZ) Sets New 1-Year High - Time to Buy?

Jazz Pharmaceuticals (NASDAQ:JAZZ) Hits New 1-Year High - What's Next...

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue decreased its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 27.1% in the fourth quarter, according to its most recent filing with the...

Jazz Pharmaceuticals (NASDAQ:JAZZ) Hits New 12-Month High - Here's What Happened

Jazz Pharmaceuticals (NASDAQ:JAZZ) Reaches New 12-Month High - Still a Buy...

Jazz Pharmaceuticals to Present Research on Epidiolex (cannabidiol) and Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting

Jazz Pharmaceuticals to Present Research on Epidiolex (cannabidiol) and Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual...

Capricorn Fund Managers Ltd Purchases New Shares in Jazz Pharmaceuticals PLC $JAZZ

Capricorn Fund Managers Ltd acquired a new position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the...

Perpetual Ltd Lowers Stake in Jazz Pharmaceuticals PLC $JAZZ

Perpetual Ltd trimmed its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 74.3% during the fourth quarter, according to the company in its most recent 13F filing with the...

Insider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells 6,000 Shares of Stock

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) Director Bruce Cozadd sold 6,000 shares of the firm's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price...

Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?

Keros Therapeutics (KROS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

JAZZ
Jazz Pharmaceuticals plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JAZZ News

JAZZJazz Pharmaceuticals plc